Insider Trading Activity Meridian Bioscience, Inc. (NASDAQ:VIVO) – Director Bought 1,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Meridian Bioscience, Inc. (NASDAQ:VIVO)

John Mcilwraith , Director of Meridian Bioscience, Inc. (NASDAQ:VIVO) reportedly Bought 1,000 shares of the company’s stock at an average price of 14.03 for a total transaction amount of $14,030.00 SEC Form

Insider Trading History For Meridian Bioscience, Inc. (NASDAQ:VIVO)

  • On 11/13/2012 Robert J Ready, Director, sold 1,800 with an average share price of $19.46 per share and the total transaction amounting to $35,028.00.
  • On 12/3/2012 Lawrence Baldini, VP, sold 32,500 with an average share price of $20.00 per share and the total transaction amounting to $650,000.00.
  • On 5/1/2013 John A Kraeutler, CEO, bought 5,000 with an average share price of $19.63 per share and the total transaction amounting to $98,150.00.
  • On 7/26/2013 Lawrence Baldini, VP, sold 32,000 with an average share price of $24.14 per share and the total transaction amounting to $772,480.00.
  • On 11/11/2013 John Kraeutler, CEO, sold 5,250 with an average share price of $25.27 per share and the total transaction amounting to $132,667.50.
  • On 11/19/2013 Lawrence Baldini, VP, sold 4,926 with an average share price of $24.26 per share and the total transaction amounting to $119,504.76.
  • On 11/21/2013 Richard Eberly, EVP, sold 4,926 with an average share price of $24.50 per share and the total transaction amounting to $120,687.00.

    • Analyst Ratings History For Meridian Bioscience, Inc. (NASDAQ:VIVO)

    • On 3/29/2016 Robert W. Baird Reiterated Rating Hold with a price target of $20.00
    • On 7/29/2016 Hilliard Lyons Downgraded rating Buy to Hold
    • On 1/25/2017 Piper Jaffray Companies Set Price Target of rating Sell with a price target of $9.00
    • On 1/31/2017 Craig Hallum Downgraded rating Buy to Hold
    • On 3/28/2017 CL King Initiated Coverage of rating Neutral to Neutral
    • On 1/26/2018 Canaccord Genuity Boost Price Target of rating Hold to Hold with a price target of $14.00 to $16.00

    Dividend Information For Meridian Bioscience, Inc. (NASDAQ:VIVO)
    Meridian Bioscience, Inc. (NASDAQ:VIVO) pays an annual dividend of $0.50 with a yield of 3.56%

    Dividend History For Meridian Bioscience, Inc. (NASDAQ:VIVO)

  • On 12/4/2012 Meridian Bioscience, Inc. announced a quarterly dividend of $0.19 with an ex dividend date of which will be payable on 12/24/2012.
  • On 4/25/2013 Meridian Bioscience, Inc. announced a quarterly dividend of $0.19 3.88% with an ex dividend date of 5/1/2013 which will be payable on 5/14/2013.
  • On 7/25/2013 Meridian Bioscience, Inc. announced a quarterly dividend of $0.19 3.13% with an ex dividend date of 8/1/2013 which will be payable on 8/15/2013.
  • On 11/7/2013 Meridian Bioscience, Inc. announced a quarterly dividend of $0.19 3.04% with an ex dividend date of 11/14/2013 which will be payable on 11/29/2013.
  • On 1/22/2014 Meridian Bioscience, Inc. announced a quarterly dividend of $0.20 3.13% with an ex dividend date of 1/30/2014 which will be payable on 2/14/2014.
  • On 4/24/2014 Meridian Bioscience, Inc. announced a quarterly dividend of $0.20 4.05% with an ex dividend date of 5/1/2014 which will be payable on 5/15/2014.
  • On 7/24/2014 Meridian Bioscience, Inc. announced a quarterly dividend of $0.20 3.99% with an ex dividend date of 7/31/2014 which will be payable on 8/14/2014.

    • Recent Trading Activity for Meridian Bioscience, Inc. (NASDAQ:VIVO)
    Shares of Meridian Bioscience, Inc. closed the previous trading session at 14.28 up +0.22 1.60% with 14.050000190734863 shares trading hands.